Physician profile
Mark Louis Bailey
NPI 1114979796
$3,653.87
in general payments reported to CMS, 2019-2025
18 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,441 · 2020: $88.00 · 2021: $242 · 2022: $51.80 · 2023: $466 · 2024: $214 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,215.64 | 2019-2020 | |
| Davol INC. | $353.17 | 2020-2024 | Arista Ah Flexitip, Phasix Mesh |
| Ethicon US, LLC | $341.45 | 2021-2025 | Surgicel Nu-Knit, Echelon; Endopath, Echelon Flex |
| W. L. Gore & Associates, INC. | $158.28 | 2019 | |
| Heron Therapeutics, INC. | $107.62 | 2023 | Zynrelef |
| Medtronic, INC. | $102.78 | 2021-2025 | Ligasure, Signia |
| Tela Bio, INC. | $71.17 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Cleerly, INC. | $58.04 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Pacira Pharmaceuticals Incorporated | $48.22 | 2023-2025 | Exparel, Iovera |
| Conmed Corporation | $41.67 | 2019 | |
| Biom'Up France Sas | $29.43 | 2021 | |
| Covidien LP | $28.37 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.47 | 2020 | |
| Acera Surgical, INC. | $20.23 | 2025 | Restrata Wound Matrix |
| Tei Biosciences INC | $16.67 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $14.18 | 2020 | |
| Integra Lifesciences Corporation | $13.41 | 2022 | |
| Acell, INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.